Hutchmed China Limited Net Income per Employee (HCM), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Hutchmed china Limited  (NASDAQ: HCM)
 

Hutchmed China Limited Net Income per Employee

HCM's Quarterly Results, Trends, Rankings, Statistics
With an income increase of 1099.19% in the fourth quarter 2025, year on year to cumulative value of $458 million, and with 780 employees, Hutchmed China Limited's income per employee grew on trailing twelve month basis to $ 586,836, this marks a new company high for all of 780 employees.
The Healthcare sector has seen employees of 29 other companies achieving higher income per employee. While income per employee total ranking has improved so far to 365, from total ranking in previous quarter at 990.


What is Income per Employee Ratio?






HCM Net Income per Employee (Dec 31 2025)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2024)
IV. Quarter
Y / Y Net Income Change 1099.19 % - - - -62.24 %
Net Income per Employee (TTM) $ 586,836 48,936 48,936 48,936 48,936
HCM's Total Ranking # 365 # 990 # # #
Seq. Net Income Change - - - - -


HCM Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 30
Healthcare Sector # 51
Overall Market # 365

Net Income per Employee Statistics
High Average Low
$ 586,836 $ -61,175 $ -462,033
(Dec 31 2025)   (Dec 31 2022)







Companies with similar Income per Employee for 12 month ending Dec 31 2025, within Healthcare Sector Income per Employee Income 12 month ending Dec 31 2025Number of Employees Dec 31 2025
Galapagos Nv  984,630.36 $ 359.390  Million 365 
United Therapeutics Corporation  953,357.14 $ 1,334.700  Million 1,400 
Silexion Therapeutics Corp  850,857.14 $ 11.912  Million 14 
Prestige Consumer Healthcare Inc   795,059.65 $ 453.184  Million 570 
Petros Pharmaceuticals inc   787,672.33 $ 2.363  Million
Heartflow Inc   773,161.33 $ 651.775  Million 843 
Chemomab Therapeutics Ltd   749,583.33 $ 8.995  Million 12 
Halozyme Therapeutics Inc   749,146.57 $ 316.889  Million 423 
Traws Pharma inc   731,294.12 $ 12.432  Million 17 
Krystal Biotech Inc   694,342.37 $ 204.831  Million 295 
Ptc Therapeutics inc   688,843.59 $ 682.644  Million 991 
Elite Pharmaceuticals Inc   667,834.38 $ 43.409  Million 65 
Black Hawk Acquisition Corporation  664,778.50 $ 1.330  Million
Illumina Inc   664,062.50 $ 850.000  Million 1,280 
Biocryst Pharmaceuticals Inc   606,577.01 $ 263.861  Million 435 
Amgen Inc   593,153.85 $ 7,711.000  Million 13,000 
Novavax inc   587,853.14 $ 440.302  Million 749 
Hutchmed china Limited  586,835.90 $ 457.732  Million 780 
Harmony Biosciences Holdings inc   541,593.86 $ 158.687  Million 293 
Entera Bio Ltd   519,954.55 $ 11.439  Million 22 
Scisparc Ltd  502,560.00 $ 12.564  Million 25 
Gilead Sciences Inc   500,588.24 $ 8,510.000  Million 17,000 
Acadia Pharmaceuticals Inc   489,974.94 $ 391.000  Million 798 
Omada Health Inc   476,262.01 $ 436.256  Million 916 
Siga Technologies Inc  475,084.55 $ 23.279  Million 49 
Incyte Corporation  452,408.58 $ 1,286.650  Million 2,844 
Sanuwave Health Inc   431,127.27 $ 23.712  Million 55 
Eli Lilly And Company  412,800.00 $ 20,640.000  Million 50,000 
Spero Therapeutics Inc   342,880.00 $ 8.572  Million 25 
Arrowhead Pharmaceuticals Inc   328,514.77 $ 233.574  Million 711 


Date modified: 2026-07-07T11:20:53+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.